Silver Book Fact

Using medical imaging to diagnose and treat stroke leads to better outcomes and shorter hospital stays, which yields a net economic benefit of about $8 billion over 10 years.

Johnston, S. Claiborne, John Rootenberg, Sarosh Katrak, W.S. Smith, and Jacob Elkins. Effect of a U.S. National Institute of Health Programme of Clinical Trials in Public Health and Costs. The Lancet. April 22, 2006; 367: 1319-27. http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=16631910&dopt=AbstractPlus

Reference

Title
Effect of a U.S. National Institute of Health Programme of Clinical Trials in Public Health and Costs
Publication
The Lancet
Publication Date
April 22, 2006
Authors
Johnston, S. Claiborne, John Rootenberg, Sarosh Katrak, W.S. Smith, and Jacob Elkins
Pages
1319-27
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Economic Value

Related Facts

  • Statin treatment soon after an acute heart attack reduces the risk of fatal heart disease or a recurrent heart attack by 24%.  
  • Several prevention/early detection interventions for cardiovascular disease have cost-effectiveness ratios of $50,000-$70,000 per life saved.  
  • Direct thrombin inhibitor reduced relative risk of venous thromboembolism
    An investigational direct thrombin inhibitor reduced relative risk of venous thromboembolism after total hip replacement surgery by 65.7%—compared to a currently available treatment.  
  • 277 medicines are currently in development to treat or prevent heart disease and stroke.  
  • Increased use of non-acute medications in primary and secondary prevention explains about 1/3 of the total reduction in cardiovascular disease mortality since 1950.